Gastroenterology Doctors in Tarzana, CA Accepting Medicare

10 Gastroenterology doctors found. Showing 1 - 10

Lori Yep Kam, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 18425 Burbank Blvd, Tarzana, CA 91356 Phone: 818-708-6000    Fax: 818-708-6009

Kenneth S Hepps, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5525 Etiwanda Ave, Ste 110, Tarzana, CA 91356 Phone: 818-996-4796    Fax: 844-406-5413

Irving Klasky, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 18425 Burbank Blvd, Suite 500, Tarzana, CA 91356 Phone: 818-708-6000    Fax: 818-708-6009

Jim Amerian, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 18425 Burbank Blvd, Suite 500, Tarzana, CA 91356 Phone: 818-708-6000    Fax: 818-708-6009

Dr. Lucien Richard Jacobs, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5525 Etiwanda Ave, Suite 110, Tarzana, CA 91356 Phone: 818-708-6070    Fax: 818-889-8005

Dr. Maurice Gourdji, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5525 Etiwanda Ave, Suite 110, Tarzana, CA 91356 Phone: 818-708-6070    Fax: 844-406-5413

Neil D Fagen, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 18411 Clark St Ste 204, Tarzana, CA 91356 Phone: 818-996-4796    Fax: 818-996-4793

Sheldon Joel Getzug, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 18425 Burbank Blvd, Suite 500, Tarzana, CA 91356 Phone: 818-708-6000    Fax: 818-708-6009

Dr. Joel A Sach, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 18425 Burbank Blvd, Suite 500, Tarzana, CA 91356 Phone: 818-708-6070    Fax: 818-708-6095

Michael Madievsky, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5525 Etiwanda Ave Ste 110, Tarzana, CA 91356 Phone: 818-996-4796    Fax: 844-406-5413

News Archive

Effects on white matter brain volume from long-term alcoholism are different for men and women

(Boston) - Researchers from Boston University School of Medicine (BUSM) and Veterans Affairs (VA) Boston Healthcare System have demonstrated that the effects on white matter brain volume from long-term alcohol abuse are different for men and women. The study, which is published online in Alcoholism: Clinical and Experimental Research, also suggests that with abstinence, women recover their white matter brain volume more quickly than men.

Opinion piece outlines new model for foreign aid

President Obama's "comments on foreign aid [in Ghana] make it all the more surprising that the only real change in our foreign assistance programs under his administration so far is in indicated spending" - Carol Adelman, director of the Center for Global Prosperity at the Hudson Institute, and Nicholas Eberstadt, a political economy scholar at the American Enterprise Institute - write in a Weekly Standard opinion piece.

Researchers present new method of wirelessly recharging medical device batteries with ultrasound

​Human beings don't come with power sockets, but a growing numbers of us have medical implants that run off electricity. To keep our bionic body parts from powering down, a group of Arizona researchers is developing a safe, noninvasive, and efficient means of wireless power transmission through body tissue.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

YM BioSciences Inc. today announced positive interim data from the first 60 patients enrolled in the Phase I/II trial for its JAK1/JAK2 inhibitor, CYT387, in myelofibrosis. The results were reported today in an oral presentation at the 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida.

Read more Medical News

› Verified 4 days ago